Fore Capital’s Organon & Co OGN Stock Holding History

Fore Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-45,000	Closed	-$1.48M	–	57
2021 Q3	$1.48M	Buy	+45,000	New	+$1.44M	0.76%	28

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fore Capital's OGN Position: Q4 2021 in Review

Fore Capital sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 45,000 shares — an estimated $1.48M sold.

Fore Capital first reported a position in OGN in Q3 2021 and held it in 1 quarter. The position peaked at $1.48M in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

Fore Capital reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
Fore Capital sold 45,000 Organon & Co shares in Q4 2021, an estimated $1.48M.
Fore Capital first reported a position in Organon & Co in Q3 2021 and held it in 1 quarter.
Fore Capital's Organon & Co position peaked at $1.48M in Q3 2021.
907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Fore Capital's 13F filing for Q4 2021, filed 11 Feb 2022.